A phase II study of Tomudex in relapsed epithelial ovarian cancer

Ann Oncol. 1995 Sep;6(7):724-5. doi: 10.1093/oxfordjournals.annonc.a059291.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neutropenia / chemically induced
  • Ovarian Neoplasms / drug therapy*
  • Quinazolines / adverse effects
  • Quinazolines / therapeutic use*
  • Remission Induction
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Quinazolines
  • Thiophenes
  • raltitrexed